| Clario–Thermo Fisher: investment, 202510– acquisition $9b in cash plus earnouts and milestones SIGNED |
2025-10-29 |
| Labomatic Instruments–Knauer: investment, 202510 acquisition of Labomatic by Knauer |
2025-10-15 |
| BigOmics–SEVERAL: investment, 202510 financing round 1st tranche $1.6m from Diffusion Capital Partners + business angels + TiVentures et al |
2025-10-08 |
| Univ London–Enamine: chemical compound libraries, 202509– supply + collab Enamine to supply fluorinated compounds for FBDD to ICR |
2025-09-23 |
| Aspect Analytics–SEVERAL: investment, 202509 financing round Series A €10m led by PMV + Capricorn Healthtech Fund II |
2025-09-09 |
| Dash Bio–SEVERAL: investment, 202507 financing round $11m led by The Aligned Fund |
2025-07-23 |
| Becton Dickinson–Waters: investment, 202507– merger acquisition of BD Biosciences & Diagnostics by Waters valued at $17.5b with $4b in cash |
2025-07-14 |
| Standard BioTools–Illumina: investment, 202506– acquisition of SomaLogic by Illumina for $350m cash upfront + $75m milestones |
2025-06-23 |
| Day Zero Diagnostics–Mérieux: investment, 202506 acquisition <$25m of assets of Day Zero Diagnostics by bioMérieux |
2025-06-16 |
| Synexa Life Sciences–Waters: mass spectrometer, 202506 supply + collab as one of first customers for new Xevo TQ Absolute XR mass spectrometer |
2025-06-10 |
| Biocrates–Bruker: investment, 202506 acquisition €na by Bruker Corporation |
2025-06-03 |
| Cytespace Africa Laboratories–MLM Medical Labs: investment, 202506 acquisition of Cytespace by MLM |
2025-06-03 |
| Bruker–Siscapa: MS-based proteomics, 2020505– collab strategic Biognosys beomces preferred service provider for Siscapa tech to biopharma customers |
2025-05-19 |
| PeptiSystems–Asahi Kasei: peptide synthesis, 202505– collab ww excl integration of Thesys ACS Ergo synthesis column of AKBA into PeptiPro platform |
2025-05-15 |
| Umlaut.bio–Baden-Würrtemberg (govt): investment, <=202505 seed financing round incl investor L-Bank via InnoGrowth BW programme |
2025-05-13 |
| Umlaut.bio–High-Tech Gründerfonds: investment, <=202505 seed financing round incl investor HTGF |
2025-05-13 |
| Umlaut.bio–LBBW: investment, <=202505 seed financing round incl investor LBBW Venture Capital |
2025-05-13 |
| Umlaut.bio–SEVERAL: investment, <=202505 seed financing round with HTGF + LBBW Venture Capital + L-Bank |
2025-05-13 |
| Biotage–KKR: investment, 202504– public takeover offer by RWK BidCo AB valuing Biotage at SEK11.6b at SEK1.65/share (KKR already owns 17%) |
2025-04-22 |
| Recipe–Bruker: investment, 202504 majority investment €na by Bruker in Recipe Chemicals + Instruments GmbH |
2025-04-16 |
| Ridom–Bruker: investment, 202504 majority investment €na by Bruker in Ridom GmbH |
2025-04-11 |
| 1st PhileKorea–Sphere Bio: cell analysis technology, 202504– distribution for Sphere Bio in South Korea by 1st PhileKorea |
2025-04-09 |
| As One Corp–Sphere Bio: cell analysis technology, 202504– distribution for Sphere Bio in Japan by 1st PhileKorea |
2025-04-09 |
| Bang Trading–Sphere Bio: cell analysis technology, 202504 distribution existent for Sphere Bio in Thailand by Bang Trading |
2025-04-09 |
| Cold Spring Biotech–Sphere Bio: cell analysis technology, 202504 distribution existent for Sphere Bio in Taiwan by Cold Spring Biotech |
2025-04-09 |
| Decode Science–Sphere Bio: cell analysis technology, 202504– distribution for Sphere Bio in Australia + New Zealand by Decode Science |
2025-04-09 |
| Everlife Research Instruments–Sphere Bio: cell analysis technology, 202504– distribution for Sphere Bio in Singapore by Everlife |
2025-04-09 |
| Gene Company–Sphere Bio: cell analysis technology, 202504 distribution existent for Sphere Bio in China + Hong Kong by Gene Company |
2025-04-09 |
| Premas Life Sciences–Sphere Bio: cell analysis technology, 202504– distribution for Sphere Bio in India + Bangladesh by Premas Life Sciences |
2025-04-09 |
| Bico–Sartorius: investment, 202504–202507 acquisition 100% of MatTek Corp + Visikol Inc on cash/debt-free basis for $80m by Sartorius Lab Holding GmbH |
2025-04-04 |
| UniteLabs–Acurio Ventures: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor Acurio Ventures |
2025-04-03 |
| UniteLabs–Lana Ventures: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor LANA Ventures |
2025-04-03 |
| UniteLabs–NAP: investment, 202504 pre-seed financing round totalling €2.77m incl lead investor NAP |
2025-04-03 |
| UniteLabs–OMA Business Angels: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor OMA Business Angels |
2025-04-03 |
| UniteLabs–Push Ventures: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor PUSH |
2025-04-03 |
| UniteLabs–SEVERAL: investment, 202504 pre-seed financing round €2.77m led by NAP |
2025-04-03 |
| Dotmatics–Siemens: investment, 202502–202507 acquisition $5.1b of Dotmatics from Insight Partners |
2025-04-02 |
| OmicScouts–Momentum Biotechnologies: investment, 202503 acquisition of OmicScouts GmbH by Momentum Biotechnologies |
2025-03-05 |
| Solventum–Thermo Fisher: investment, 202502– acquisition $4.1b in cash of purification + filtration business by Thermo Fisher |
2025-02-25 |
| DeepEn–MBG Thüringen: investment, 202502 seed financing round totalling € 7-digit incl investor MBG Thüringen |
2025-02-17 |
| DeepEn–SEVERAL: investment, 202502 seed financing round € 7-digit from bm|t + MBG Thüringen + Sparkasse-Jena-Holzland |
2025-02-17 |
| DeepEn–Sparkassen (DE): investment, 202502 seed financing round totalling € 7-digit incl investor Sparkasse Jena-Saale-Holzland |
2025-02-17 |
| DeepEn–Thuringia (govt): investment, 202502 seed financing round totalling € 7-digit incl investor bm|t |
2025-02-17 |
| Mobilion–ICR: public relations, 202502 service existent ICR Healthcare is media contact |
2025-02-13 |
| Mobilion–Scott Partnership: public relations, 202505 service existent Scott PR is media contact |
2025-02-13 |
| Stellaromics–Catalyst4: investment, 202502 financing round Series B totalling $80m incl lead investor Catalyst4 |
2025-02-11 |
| Stellaromics–Oak Street Communications: public relations, 202502 service existent Oak Street is media contact for Stellaromics |
2025-02-11 |
| Stellaromics–SEVERAL: investment, 202502 financing round Series B $80m led by Catalyst4 |
2025-02-11 |
| Stellaromics–Stanford Univ: investment, 202502 financing round Series B totalling $80m incl co-investor Stanford University Ventures |
2025-02-11 |
| Akribion–Bruker: investment, 202502 seed financing round totalling €8m incl co-investor Bruker Invest |
2025-02-04 |
| Akribion–High-Tech Gründerfonds: investment, 202502 seed financing round totalling €8m incl co-investor HTGF |
2025-02-04 |
| Akribion–Optimum Strategic Communications: public relations, 202502 service existent by Optimum |
2025-02-04 |
| Akribion–SEVERAL: investment, 202502 seed financing round €8m led by Carma Fund + RV Invest |
2025-02-04 |
| Knauer–Labomatic Instruments: liquid chromatography 202502– collab strategic combining HPLC offerings to customers incl sales + service |
2025-02-03 |
| Bureau Veritas–SGS: investment, 202501– confirmed merger discussion |
2025-01-15 |
| Owlstone–Aviva: investment, 202501 financing round Series E first closing totalling $27m incl existing + co-investor Aviva Ventures |
2025-01-15 |
| Owlstone–Gates Foundation: grant, 202404– initial $1.5m grant to develop breat-based diagnostics for developing countries from Gates Foundation |
2025-01-15 |
| Owlstone–Horizons Ventures: investment, 202501 financing round Series E first closing totalling $27m incl existing + co-investor Horizon Ventures |
2025-01-15 |
| Owlstone–SEVERAL: investment, 202501 financing round Series E first closing $27m led by Ventura Capital |
2025-01-15 |
| Owlstone–Ventura Capital: investment, 202501 financing round Series E first closing totalling $27m incl existing + lead investor Ventura Capital |
2025-01-15 |
| SpinChip Diagnostics–Mérieux: investment, 202501– acquisition of remaining 80% of SpinChip for €111m in cash by bioMérieux |
2025-01-13 |
| Akoya Biosciences–Quanterix: investment, 202501– merger acquisition with former Quanterix shareholders owning 70% ANNOUNCED |
2025-01-10 |
| Univ Zurich–Bruker: NMR spectrometer, 202412 supply 1.2 GHz Ascend NMR spectrometer to Swiss High-field NMR Facility at UZH |
2024-12-20 |
| Syncell–SEVERAL: investment, 202412 financing round Series A $15m led by Taiwania Capital Bio Fund bringing total raised to $30m |
2024-12-11 |
| Syncell–Taiwania Capital: investment, 202412 financing round Series A totalling $15m incl lead investor Taiwania Capital Bio Fund |
2024-12-11 |
| Bruker–Ion Opticks: liquid chromatography, 202412– supply costum chromatography column for MS-based proteomic services to Biognosys |
2024-12-05 |
| HexagonFab–Merck (DE): investment, 202412 financing round Series A totalling £6.6m of Abselion incl lead investor M Ventures |
2024-12-04 |
| HexagonFab–SEVERAL: investment, 202412 financing round Series A £6.6m of Abselion led by M Ventures |
2024-12-04 |
| miDiagnostics–Alychlo: investment, 202412 financing round Series D totalling €30m incl existing + co-investor Alychlo |
2024-12-04 |
| miDiagnostics–Pamica: investment, 202412 financing round Series D totalling €30m incl existing + co-investor Pamica |
2024-12-04 |
| miDiagnostics–SEVERAL: investment, 202412 financing round Series D €30m led by Thermo Fisher Scientific |
2024-12-04 |
| miDiagnostics–Thermo Fisher: investment, 202412 financing round Series D totalling €30m incl lead investor Thermo Fisher Scientific |
2024-12-04 |
| miDiagnostics–VMF Invest: investment, 202412 financing round Series D totalling €30m incl existing + co-investor VMF Invest |
2024-12-04 |
| Bico–RAG: investment, 202411 acquisition €26m of Nanoscribe from Bico Group by LAB14 GmbH |
2024-11-21 |
| Tagomics–Agilent: genomic technology, 202411– collab co-marketing agreem of Interlace multiomics services using Agilent genomic profiling products |
2024-11-20 |
| Tagomics–Zyme Communications: public relations, 202411 service existent by Zyme |
2024-11-20 |
| Mainz Biomed–Thermo Fisher: colorectal cancer screening test, 202411– collab developm + commercialisation assays for mRNA-based CRC screening tests |
2024-11-12 |
| PrognomiQ–aMoon: investment, 202411 financing round Series D totalling $34m incl existing + co-investor aMoon |
2024-11-05 |
| PrognomiQ–Bruker: investment, 202411 financing round Series D totalling $34m incl existing + co-investor Bruker |
2024-11-05 |
| PrognomiQ–Catalio Capital: investment, 202411 financing round Series D totalling $34m incl existing + co-investor Catalio Capital Management |
2024-11-05 |
| PrognomiQ–Invus Group: investment, 202411 financing round Series D totalling $34m incl existing + co-investor Invus |
2024-11-05 |
| PrognomiQ–OTHER: investment, 202411 financing round Series D totalling $34m incl new large strategic diagnostics investor |
2024-11-05 |
| PrognomiQ–SEVERAL: investment, 202411 financing round Series D $34m led by Seer Inc |
2024-11-05 |
| Danaher–Ion Opticks: liquid chromatography, 202410– collab co-marketing of Aurora Series XS LC columns with ZenoTOF line MS systems of Sciex |
2024-10-25 |
| Dash Bio–SEVERAL: investment, 202410 seed financing round $6.5m led by Freestyle Capital |
2024-10-24 |
| Alderley Analytical–Synexa Life Sciences: investment, 202410 acquisition of Alderley Analytical Ltd by Synexa |
2024-10-07 |
| Bureau Veritas–Mérieux: investment, 202410– acquisition €360m of global food testing of Bureau Veritas by Mérieux NutriSciences |
2024-10-07 |
| Danaher–CrestOptics: spinning disk microscopy, 202410– collab integration of Cicero spinning disk unit into Thunder Imager of Leica Microsystems |
2024-10-07 |
| Agilent–National Univ Singapore: metabolomics, 202410– collab establishment NUS-Agilent CoE in Cell Metabolism incl supply of Agilent instruments |
2024-10-04 |
| Dynamic Biosensors–Bruker: investment, 202410 acquisition €na of Dynamic Biosensors GmbH + integration in Bruker Biosensors business |
2024-10-02 |
| Virscidian–Dotmatics: investment, 202409 acquisition of Virscidian by Dotmatics |
2024-09-25 |
| Ion Opticks–Adelis Equity Partners: investment, 202409 strategic investment by Adelis Equity Partners |
2024-09-10 |
| Immunocore–Danaher: data management software, 202409– supply Genedata SDMS for discovery of TCR therapeutics |
2024-09-05 |
| Alphalytik Pharmaservice–Certania: investment, 202409 acquisition of Alphalytik Pharmaservice GmbH by Certania |
2024-09-04 |
| Irubis–SEVERAL: investment, 202408 financing round pre-Series A led by new investor BioProcess360 Partners |
2024-08-29 |
| mzio–Bremen (govt): grant, 202408 grant funding €150k from BAB co-funded by EU |
2024-08-21 |
| Genedata–Danaher: investment, 202408 acquisition of Genedata that will join Danaher’s Life Science segment |
2024-08-19 |
| Bruker–Novalix: drug discovery technology, 202408– strategic collab to enable new paradigms in drug discovery |
2024-08-07 |
| Novalix–Bruker: investment, 202408 strategic minority investment €na by Bruker |
2024-08-07 |
| Thermo Fisher–Biomatter Designs: enzyme design, 202408 supply existent customer Thermo Fisher |
2024-08-05 |
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spec-capital-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
